Literature DB >> 7495725

Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host disease.

T Tanaka1, Y Ohtsuka, H Yagita, Y Shiratori, M Omata, K Okumura.   

Abstract

We have investigated the involvement of adhesion molecules in the lymphocyte infiltration associated with acute intestinal graft-versus-host disease (GVHD) induced by injection of C3H lymph node cells into irradiated (C3H x DBA/2)F1 mice. First we analyzed the expression profile of adhesion molecules including alpha 1, alpha 2, alpha 4, alpha 5, alpha 6, alpha L and beta 7 integrins, CD44 and L-selectin of lymphocytes from lymph nodes and gut mucosa in normal mice. In normal mice, intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) uniquely showed increased expression of alpha 1, alpha 2 and beta 7 integrins, and decreased expression of L-selectin compared with that of lymphocytes of the lymph nodes and Peyer's patches. In mice with GVHD, IEL and LPL of donor lymph node cells origin underwent phenotypic changes characterized by the increased expression of alpha 1, alpha L and beta 7 integrins, and the loss of L-selectin. The expression profile of adhesion molecules on IEL and LPL of GVHD mice resembled that of normal mice except for the lack of alpha 2 integrin. Treatment of GVHD mice with anti-alpha 1, -alpha 4 or -beta 7 integrin antibody alone partially prevented the mucosal pathology of intestinal GVHD, whereas only mice treated with anti-alpha 1 showed reduced donor lymphocytic infiltration into the intestinal mucosa. In contrast, treatment with anti-alpha L or anti-CD44 antibody did not affect the intestinal GVHD. Furthermore, dual blockade of both alpha 1 and alpha 4 integrins completely inhibited the mucosal pathology and donor lymphocyte infiltration of intestinal GVHD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495725     DOI: 10.1093/intimm/7.8.1183

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

Review 1.  The regulation of integrin function by divalent cations.

Authors:  Kun Zhang; JianFeng Chen
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.

Authors:  Elisha Waldman; Sydney X Lu; Vanessa M Hubbard; Adam A Kochman; Jeffrey M Eng; Theis H Terwey; Stephanie J Muriglan; Theo D Kim; Glenn Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

3.  Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Authors:  Alan M Hanash; Lucy W Kappel; Nury L Yim; Rebecca A Nejat; Gabrielle L Goldberg; Odette M Smith; Uttam K Rao; Lindsay Dykstra; Il-Kang Na; Amanda M Holland; Jarrod A Dudakov; Chen Liu; George F Murphy; Warren J Leonard; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

Review 4.  Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).

Authors:  Bruce R Blazar; William J Murphy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

5.  Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis.

Authors:  A R de Fougerolles; A G Sprague; C L Nickerson-Nutter; G Chi-Rosso; P D Rennert; H Gardner; P J Gotwals; R R Lobb; V E Koteliansky
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

6.  Effects of VLA-1 Blockade on Experimental Inflammation in Mice.

Authors:  Ryuichi Totsuka; Takaaki Kondo; Shigeki Matsubara; Midori Hirai; Yoichi Kurebayashi
Journal:  Kobe J Med Sci       Date:  2016-07-05

7.  Expression of the alpha1beta1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells.

Authors:  Itamar Goldstein; Shomron Ben-Horin; Jianfeng Li; Ilan Bank; Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

8.  Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration.

Authors:  Li Liu; Barbara Schwartz; Yoshiaki Tsubota; Elaine Raines; Hiroaki Kiyokawa; Karyn Yonekawa; John M Harlan; Lynn M Schnapp
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 9.  Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease.

Authors:  Minghui Li; Kai Sun; Lisbeth A Welniak; William J Murphy
Journal:  Expert Opin Pharmacother       Date:  2008-09       Impact factor: 3.889

Review 10.  The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Jonathan B Meddings; Keith A Sharkey; V Wee Yong
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.